By Gary Wells | 04 December 2013

This report contains quarterly statistics data for markets around the world.

By Jason Clarkson, Michael G. Sturm, Paul R. Houchens | 02 December 2013

Insurance plan information for the Federal individual exchange market and 32 states has been released—giving consumers and the health insurance industry the first opportunity to view the landscape of the new exchange market.

By Susan J. Forray | 02 December 2013

What are implications for insurers of the U.S. Tax Court's Acuity case ruling?

By Colette Dunn | 21 November 2013

Financial advisers need to engage with people about their retirement savings and the income they need for a comfortable old age.

By Richard W. Holloway, Wen Yee Lee | 21 November 2013

This e-Alert summarises the changes proposed by BNM in a recent concept paper, Life Insurance and Family Takaful Framework, intended to improve insurance and Takaful services in Malaysia.

By Milliman Employee Benefits Research Group | 20 November 2013

CAB 13-9: This Client Action Bulletin briefly describes key guidance from the Departments of Treasury (IRS), Labor (DOL), and Health and Human Services (DHHS) released Apr. 1-Sept. 30, 2013 and applicable to group health plans and insurance in plan/policy years that begin in 2014.

By Paul R. Houchens | 19 November 2013

The individual health insurance market has experienced more significant changes in terms of profitability, claims cost, and administrative expenses relative to the group insurance markets in the years following the enactment of the ACA.

By Richard W. Holloway, Sanket Kawatkar, Shamit Gupta | 19 November 2013

In this edition of the Asia e-alert, we present a summary of the new RBC Framework.

By Hans K. Leida | 19 November 2013

The November 14, 2013 announcement that health insurance issuers would be permitted to renew certain canceled health insurance policies has raised new questions for the individual and small group marketplaces in 2014.

By Nicholas Kinrade, William Coatesworth | 14 November 2013

The regulatory objectives of Solvency II and the Swiss solvency test are consistent, in what areas do these two regimes take a different approach?